News
-
Aptar Pharma is introducing two new eDevices, an electronic dose counter and an electronic lockout mechanism for nasal and sub-lingual spray pumps. The new devices can help products meet regulatory requirements for the delivery of… Read more . . .
-
According to news reports, a Florida man lost his teeth and part of his tongue when the battery in an e-cigarette exploded in his mouth on February 14. The explosion also started a fire in… Read more . . .
-
A jury has awarded $18 million to Sunovion Pharmaceuticals after finding that Mylan willfully infringed on patents for Xopenex levalbuterol hydrochloride inhalation solution when its subsidiary Dey marketed generic versions of the product. The trial… Read more . . .
-
A Dallas, TX company called Wholistic Herbs Inc. has recalled all of the nasal spray products it distributed from March 2009 through February 2012 under the name “Koff & Kold” and “Kold Sore” after an… Read more . . .
-
Alexza Pharmaceuticals says that the Day 80 Assessment Report it has received from the European Medicines Agency (EMA) regarding its Marketing Authorization Application (MAA) for Adasuve Staccato loxapine indicates that the report “outlines major objections… Read more . . .
-
Finnish pharmaceutical company Orion Corporation has announced its intention to continue development of a generic budesonide/formoterol DPI despite the fact that “equivalence with the reference product, which is required under the guideline of the European… Read more . . .
-
Aptuit is a worldwide Contract Research Organization, collaborating with all the major Pharma and Biotech companies in support of various drug discovery and development projects. To efficiently support on going activities and needs, we are… Read more . . .
-
Insmed Incorporated has announced that it will go ahead with two clinical trials of its Arikace liposomal amikacin for inhalation for non-tuberculous mycobacteria (NTM) lung disease and for P. aeruginosa infections in CF patients despite… Read more . . .
-
Update 3/7/2012: The FDA issues a warning letter on inhalable caffeine. Update 2/19/2012: The FDA says it will review the safety and legality of AeroShot inhaled caffeine. In 2008, Harvard professor David Edwards gave a… Read more . . .
-
A new report from IbisWorld foresees a positive outlook for nebulizer sales after estimated annualized growth rate of 6.2% from 2007 to 2012. The report suggests that an aging population and increasing diagnoses of respiratory… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.